Unconfigured Ad
Collapse
Any topic/question that does not fit into the subcategories below. If you're unsure of where to put something, ask in here!
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by nilshomer, 05-08-2010, 02:19 PM
|
52 responses
118,261 views
0 reactions
|
Last Post
by archana87
04-23-2019, 01:18 PM
|
||
|
Started by ssing, 07-26-2012, 04:23 PM
|
1 response
2,332 views
0 reactions
|
Last Post
by YazBraimah
08-02-2012, 10:42 AM
|
||
|
Started by BurlEarl, 06-27-2012, 09:11 AM
|
3 responses
2,926 views
0 reactions
|
Last Post
by Geoffreyion
08-01-2012, 04:26 AM
|
||
|
Started by niceday, 05-31-2011, 01:24 AM
|
5 responses
4,488 views
0 reactions
|
Last Post
by Genquest
07-31-2012, 11:44 PM
|
||
|
Started by MAdkisson, 07-30-2012, 01:49 PM
|
1 response
3,398 views
0 reactions
|
Last Post
by pmiguel
07-31-2012, 08:25 AM
|
||
|
Started by Orr Shomroni, 07-31-2012, 06:15 AM
|
0 responses
1,713 views
0 reactions
|
Last Post
by Orr Shomroni
07-31-2012, 06:15 AM
|
||
|
Started by luckylove, 07-30-2012, 01:17 AM
|
0 responses
2,532 views
0 reactions
|
Last Post
by luckylove
07-30-2012, 01:17 AM
|
||
|
Started by rbagnall, 07-27-2012, 04:54 PM
|
0 responses
2,228 views
0 reactions
|
Last Post
by rbagnall
07-27-2012, 04:54 PM
|
||
|
Started by rathankar, 07-26-2012, 03:44 AM
|
5 responses
1,902 views
0 reactions
|
Last Post
|
||
|
Started by cknox, 07-25-2012, 12:39 PM
|
0 responses
1,045 views
0 reactions
|
Last Post
by cknox
07-25-2012, 12:39 PM
|
||
|
Started by finfin, 07-23-2012, 07:07 AM
|
0 responses
1,615 views
0 reactions
|
Last Post
by finfin
07-23-2012, 07:07 AM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 08-24-2026, 10:32 AM
|
0 responses
15 views
0 reactions
|
Last Post
by SEQadmin2
08-24-2026, 10:32 AM
|
||
|
Started by SEQadmin2, 08-20-2026, 11:17 AM
|
0 responses
35 views
0 reactions
|
Last Post
by SEQadmin2
08-20-2026, 11:17 AM
|
||
|
Started by SEQadmin2, 08-18-2026, 10:05 AM
|
0 responses
37 views
0 reactions
|
Last Post
by SEQadmin2
08-18-2026, 10:05 AM
|